Articles written specifically for the GLP or the articles that are reposted from other sources (sometimes in modified form) with permission list the source as Genetic Literacy Project. Excerpted articles list the original media outlet as the source. Excerpts are posted under guidelines for Fair Use and Creative Commons for educational nonprofits (501c3). The GLP’s Fair Use policy for posting excerpts and using images is explained here.
IIevX rR

Steven Pinker on CRISPR bioethical constraints and critics: ‘Get out of the way’

Steven Pinker | 
Professor Steven Pinker of Harvard has been one of the most outspoken advocates for more gas and less brakes in ...
Screen Shot at AM

Genetically engineered animals with CRISPR-Cas9 edited genes are being developed

Paul Knoepfler | 
As CRISPR-Cas9 gene editing technology has advanced in the last few years, the number of genetically modified animals made with ...

Is ‘genetically modified human’ an accurate term if germline editing ever comes into use?

Paul Knoepfler | 
During the still ongoing discussions of genetic modification in the human germ line and potentially in actual human beings in ...

Does size matter enough to inject stem cells directly into your penis?

Paul Knoepfler | 
Does size matter? Can a man get bigger and could he do it via stem cells? An increasing number of ...

Can human germline genetic modification research proceed with ethics in mind?

Lisa Ikemoto | 
I have been following the reports about genetic editing technology with concern. The fact that some scientists are calling for ...

Where does the world stand on human germline gene editing?

Paul Knoepfler | 
In a still ongoing on-line poll, readers of the Knoepfler Lab Stem Cell blog show a pattern of consistently favoring a moratorium ...

New stem cell clinic feigns government approval with provocative name

Paul Knoepfler | 
Some American stem cell clinics that operate without FDA approval can give the appearance of being in the mainstream of ...

Finding a happy medium in regulation of stem cell research

Paul Knoepfler | 
When I started blogging in 2010 the stem cell arena was a very different place. Back then the hot topic ...

Does FDA underregulate stem cell treatments?

Paul Knoepfler | 
NBC News did a big on-line story followed by a NBC Nightly News Segment on dubious stem cell therapies on Friday. Normally a ...

Interview with FDA on dubious direct-to-consumer stem cell practices

Paul Knoepfler | 
I requested an interview with the FDA to cover the key pressing issues in this direct-to-consumer stem cell interventions. I ...

UK scientists’ response to mitochondrial transfer criticism by prominent stem cell researcher

Peter Braude, Robin Lovell-Badge | 
Dear Professor Knoepfler, Whilst we take no role in lobbying Parliament, we believe it behoves us to defend the findings ...

Pominent US biologist lectures UK Parliament: ‘Three-parent’ IVF too uncertain to be safe

Paul Knoepfler | 
This open letter was written by Paul Knoepfler, associate professor in the Department of Cell Biology and Human Anatomy, the Genome ...

Epigenetic cellular controls key for sperm and cancers

Paul Knoepfler | 
Sometimes in science there are unexpected threads tying seemingly very different things together. Unraveling the knots in these threads can ...

Retracted STAP stem cell papers first rejected at another journal; reviewers’ comments now public

Paul Knoepfler | 
Before the two STAP cell papers were published in Nature in January of 2014, much of the same data was ...

Duke stem cell trial for autism dangerously speculative?

Paul Knoepfler | 
Can stem cells be used to treat autism? At this point the jury remains out on that question, but a ...

Brain cancer may have rogue stem cell origin, option for treatment

Paul Knoepfler | 
Glioblastoma and other related malignant glioma tumors including diffuse intrinsic pontine glioma (DIPG) are some of the most devastating of ...

‘Right to try’ law, for profit stem cells make Colorado wild West of non-FDA clinical trials

Paul Knoepfler | 
Colorado passed a new law supported by the ultra-conservative Goldwater Institute, the so-called Right To Try Law. This law allows ...

Further advancement for MS stem cell treatments

Paul Knoepfler | 
There is more good news from leading stem cell biotech Advanced Cell Technology (ACT) on preclinical rodent studies using stem ...

Stem cell scientist outlines his top five challeges for embryonic stem cell nuclear transfer

Paul Knoepfler | 
It was intriguing last week to read about another advance in somatic cell nuclear transfer (SCNT)-based therapeutic cloning of human ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists